---
figid: PMC7608616__41419_2020_3144_Fig3_HTML
figlink: pmc/articles/PMC7608616/figure/Fig3/
number: F3
caption: The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits the PI3K and the mTOR pathway,
  which interferes with MCL-1 stability, thereby releasing BIM to activate BAX/BAK,
  leading to cytochrome c release and apoptosis. Inhibition of PI3Kδ by idelalisib
  and AKT by ibrutinib and MK2206 further blocks the PI3K/AKT-mediated signaling.
  Inhibition of these pathways reduces MCL-1 levels, leading to BIM release and apoptosis.
pmcid: PMC7608616
papertitle: Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance.
reftext: Isha Kapoor, et al. Cell Death Dis. 2020 Nov;11(11):941.
pmc_ranked_result_index: '25425'
pathway_score: 0.9397776
filename: 41419_2020_3144_Fig3_HTML.jpg
figtitle: Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7608616__41419_2020_3144_Fig3_HTML.html
  '@type': Dataset
  description: The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits the PI3K and the mTOR
    pathway, which interferes with MCL-1 stability, thereby releasing BIM to activate
    BAX/BAK, leading to cytochrome c release and apoptosis. Inhibition of PI3Kδ by
    idelalisib and AKT by ibrutinib and MK2206 further blocks the PI3K/AKT-mediated
    signaling. Inhibition of these pathways reduces MCL-1 levels, leading to BIM release
    and apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - GSK3B
  - PTEN
  - BCL2L11
  - BAK1
  - BAX
  - BCL2
  - BEZ-235H
  - Ibrutinib
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: BIM
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: BAX/BAK
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: BAX/BAK
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: BCL-2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
chemicals:
- word: BEZ-235H
  source: MESH
  identifier: C531198
- word: Ibrutinib
  source: MESH
  identifier: C551803
diseases: []
figid_alias: PMC7608616__F3
redirect_from: /figures/PMC7608616__F3
figtype: Figure
---
